Back
Results - Announcements
Unichem Laboratories Ltd consolidated sales up 10% on year in Q2FY2026, net profit soared by 280.11%
11-Aug-2026, 05:50
Unichem Laboratories Ltd share price ticked higher by 4.05% to Rs 507.95 after the company's net profit surged by 280.11% to Rs 41.47 crore, while revenue from operations increased 10% to Rs 632.62 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.56 lakh crore, easing 4.63%. It has improved by 0.56% over last one week and heading higher by 13.27% in last one month while the market capitalization of Unichem Laboratories Ltd has inched up 1.65% and 40.05% in the same period respectively. Profit before tax (PBT) of Unichem Laboratories Ltd stood at Rs 48.99 crore in Q2 FY26, nosediving by 643.13% year-on-year, and surging by 160.72% quarter-on-quarter. EBITDA came in at Rs 54 crore, jumping 246.71% YoY and rallying 124.41% sequentially. Total expenses saw a slight increase of 6.19% to Rs 592.62 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 190.02 crore, inching up 3.25% YoY, while employee benefits expense was at Rs 103.31 crore, improving by 11.27% YoY. For the TTM ended FY26, revenue from operations tick up 4.31% to Rs 2201.85 crore, while net profit jumped 83.86% to Rs 252.84 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 22910% to Rs 121.11 crore, and PBT surged 89.13% to Rs 292.38 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 3.64 crore in FY26, as against Rs 7.02 crore in FY25. Unichem Laboratories Ltd inched up 3.10% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.
Unichem Laboratories Ltd share price ticked higher by 4.05% to Rs 507.95 after the company's net profit surged by 280.11% to Rs 41.47 crore, while revenue from operations increased 10% to Rs 632.62 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.56 lakh crore, easing 4.63%. It has improved by 0.56% over last one week and heading higher by 13.27% in last one month while the market capitalization of Unichem Laboratories Ltd has inched up 1.65% and 40.05% in the same period respectively. Profit before tax (PBT) of Unichem Laboratories Ltd stood at Rs 48.99 crore in Q2 FY26, nosediving by 643.13% year-on-year, and surging by 160.72% quarter-on-quarter. EBITDA came in at Rs 54 crore, jumping 246.71% YoY and rallying 124.41% sequentially. Total expenses saw a slight increase of 6.19% to Rs 592.62 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 190.02 crore, inching up 3.25% YoY, while employee benefits expense was at Rs 103.31 crore, improving by 11.27% YoY. For the TTM ended FY26, revenue from operations tick up 4.31% to Rs 2201.85 crore, while net profit jumped 83.86% to Rs 252.84 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 22910% to Rs 121.11 crore, and PBT surged 89.13% to Rs 292.38 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 3.64 crore in FY26, as against Rs 7.02 crore in FY25. Unichem Laboratories Ltd inched up 3.10% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 2.56% during the same period.